genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Aging
Exercise Started Later in Life Helps Keep Muscles Youthful; Holds Back…
Drug Discovery
Programmable Biosensor Chip Uses Single Molecules to Detect Multiomic Molecular Interactions
Cell Therapy
Human Genomic Safe Harbors Identified for Gene and Cell Therapy
Artificial Intelligence
Artificial Intelligence Could Help Detect Onset of Cardiovascular Disease
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Soft Off-Gas Sensor for CHO Cultures
Bioprocessing
Using Waddington’s Landscape to Bioprocess Stem Cells
Bioprocessing
Biomanufacturing Islands for Faster, More Efficient Cell Line Development
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Coronavirus
Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists
Top 10 Spatial Biology Companies
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Hematologic Conditions
Hematologic Conditions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hematologic Conditions
Response to Blood Platelet Disorder Therapy Predicted by Novel 3D Model
Hematologic Conditions
Potential Protein Protection for Kidneys from Cancer Therapies Discovered
Hematologic Conditions
Chimerix Licenses Cantex’s CX-01 for AML after Promising Phase II Results
Hematologic Conditions
After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045
Hematologic Conditions
AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals
Hematologic Conditions
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Hematologic Conditions
Reversible Technique Developed for Stem Cell Expansion
Hematologic Conditions
Curcumin Shown to Inhibit DYRK2 and Reduce Cancer Burden
Hematologic Conditions
CRISPR Improves Red Blood Cell Transfusion Success
Hematologic Conditions
Model Wound System Created that Self Heals
Hematologic Conditions
Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial
Hematologic Conditions
Nohla and UC Davis Ink Manufacturing Deal for Off-the-Shelf Donor Stem...
Hematologic Conditions
Novartis Acquires Selexys Pharmaceuticals
Hematologic Conditions
Takeda to Co-Develop Gencia’s MAGR Drugs in Up-to-$500M+ Partnership
Hematologic Conditions
Blood-Cleansing Biospleen Developed
Scroll Up
![Synthetic biologists at the University of Bristol have succeeded in generating laboratory-made red blood cells with rare blood group types. [Dr. Ashley Toye/University of Bristol]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr30_2018_UnivBristol_GeneEditedRedBloodCells1901781571-324x160.jpg "CRISPR Improves Red Blood Cell Transfusion Success")
